Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Male osteoporosis

A. Giusti, G. Bianchi

136-143

28-07-2014

https://doi.org/10.4081/reumatismo.2014.786

2773

PDF: 1609
Management of cutaneous discomfort in patients with scleroderma: a clinical trial

M. Muratore, L. Quarta, L. Raho, D. Costanza, S. Frisenda, F. Calcagnile, A. Grimaldi, E. Quarta, D. Carati, M. Guido, A. Zizza, G. Alessandrini

240-247

18-12-2013

https://doi.org/10.4081/reumatismo.2013.240

3474

PDF: 1104
Octogenarian with an untreated femoral neck fracture: upright position during the postoperative course after aortic valve replacement

M. Polastri, L. Di Marco, S. Cantagalli, M. Di Eusanio

26-28

30-06-2015

https://doi.org/10.4081/reumatismo.2015.797

1397

PDF: 752
Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

121-126

https://doi.org/10.4081/reumatismo.2006.121

1786

PDF: 1733
Effects of secukinumab on serum adipocytokines: preliminary data

A. Fassio, D. Gatti, P. Gisondi, G. Girolomoni, O. Viapiana, A. Giollo, M. Zamboni, M. Rossini, L. Idolazzi

105-110

21-09-2017

https://doi.org/10.4081/reumatismo.2017.953

2852

PDF: 1518
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment

M. Benucci, A. Damiani, A. Arena, M. Infantino, M. Manfredi, F. Li Gobbi

163-165

16-12-2016

https://doi.org/10.4081/reumatismo.2016.911

3120

PDF: 819
Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

Ebru Atalar, Hatice Ecem Konak, Pınar Akyüz Dağlı, Bahar Özdemir Ulusoy, Özlem Karakaş, Kevser Orhan, Rezan Koçak Ulucaköy, Esra Kayacan Erdoğan, Serdar Can Güven, Orhan Küçükşahin, İsmail Doğan, Hakan Babaoğlu, Yüksel Maraş, Şükran Erten, Ahmet Omma, Berkan Armağan

26-06-2025

https://doi.org/10.4081/reumatismo.2025.1792

1671

PDF: 56
Guidelines for the diagnosis, prevention and management of osteoporosis

M. Rossini, S. Adami, F. Bertoldo, D. Diacinti, D. Gatti, S. Giannini, A. Giusti, N. Malavolta, S. Minisola, G. Osella, M. Pedrazzoni, L. Sinigaglia, O. Viapiana, G. C. Isaia

1-39

23-06-2016

https://doi.org/10.4081/reumatismo.2016.870

20029

PDF: 9681
Italian guidelines for the diagnosis and treatment of Paget’s disease of bone

S. Adami, P. Bartolazzi, M.L. Brandi, A. Falchetti, P. Filipponi, S. Gonnelli, G. Bianchi, G.C. Isaia, R. Nuti

153-168

https://doi.org/10.4081/reumatismo.2007.153

1668

PDF: 5973
Italian Society of Rheumatology recommendations for the management of gout

M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

4-21

28-03-2013

https://doi.org/10.4081/reumatismo.2013.4

5781

PDF: 1556
Somatoform disorders and rheumatic diseases: from DSM-IV to DSM-V

A. Alciati, F. Atzeni, P. Sgiarovello, P. Sarzi-Puttini

98-102

06-06-2014

https://doi.org/10.4081/reumatismo.2014.770

1989

PDF: 1238
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

268-274

https://doi.org/10.4081/reumatismo.2006.268

1606

PDF: 2723
Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology

M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese

11-09-2024

https://doi.org/10.4081/reumatismo.2024.1781

1855

PDF: 924
On the main stages of the history of intra-articular therapy

P. Marson, G. Pasero, L. Punzi, G. Zanchin

262-268

https://doi.org/10.4081/reumatismo.2007.262

1405

PDF: 1151
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

07-04-2025

https://doi.org/10.4081/reumatismo.2025.1817

1710

PDF: 50

SUPPLEMENTARY MATERIAL: 304
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

G. Andrisani, E. Gremese, L. Guidi, A. Papa, M. Marzo, C. Felice, D. Pugliese, A. Armuzzi

75-78

27-05-2013

https://doi.org/10.4081/reumatismo.2013.75

3022

PDF: 928
Rééducation Posturale Globale in musculoskeletal diseases: scientific evidence and clinical practice

C. Vanti, A. Generali, S. Ferrari, T. Nava, D. Tosarelli, P. Pillastrini

192-201

https://doi.org/10.4081/reumatismo.2007.192

3711

PDF: 3915
Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

267-272

https://doi.org/10.4081/reumatismo.2005.267

1086

PDF: 1744
Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

299-303

https://doi.org/10.4081/reumatismo.2007.299

951

PDF: 759
Predictors of thickened carotid intima media thickness among well controlled lupus nephritis patients in a Malaysian tertiary centre

S.S. Shaharir, M.S. Mohamed Said, N.CT. Kong

341-349

20-12-2012

https://doi.org/10.4081/reumatismo.2012.341

2299

PDF: 939
How much does an antiinflammatory treatment cost?

D. Gatti, O. Viapiana, G. Colombo, S. Adami

248-252

https://doi.org/10.4081/reumatismo.2010.248

1281

PDF: 689
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

16-20

10-04-2020

https://doi.org/10.4081/reumatismo.2020.1243

1652

PDF: 806
Methotrexate in the treatment of peripheral arthritis in ulcerative colitis

R. Peluso, M. Atteno, S. Iervolino, V. Bruner, F. Caso, L. Costa, M. Raimodo, M. Lofrano, F. Manguso, R. Scarpa

15-20

https://doi.org/10.4081/reumatismo.2009.15

1283

PDF: 982
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

83-89

09-09-2016

https://doi.org/10.4081/reumatismo.2016.875

1918

PDF: 952

IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 545
A short history of anti-rheumatic therapy - V. Analgesics

G. Pasero, P. Marson

55-60

https://doi.org/10.4081/reumatismo.2011.55

1546

PDF: 1737
Clinical profile of patients with lupus psychosis in a Colombian cohort

M. Muñoz-Urbano, J. Sánchez-Bautista, A. Ramirez, D.C. Quintero-González, Y. Santamaria-Alza, A.L. Vanegas-García

13-09-2022

https://doi.org/10.4081/reumatismo.2022.1483

1439

PDF: 743
Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management

R. Torta, F. Pennazio, V. Ieraci

92-97

06-06-2014

https://doi.org/10.4081/reumatismo.2014.769

2939

PDF: 1894
Gait analysis in hip viscosupplementation for osteoarthritis: a case report

L. Di Lorenzo

199-202

31-10-2013

https://doi.org/10.4081/reumatismo.2013.199

3022

PDF: 884
Rheumatologic rehabilitation: the great expectation for rheumatic patients

S. Maddali Bongi, M. Matucci Cerinic

1-6

16-03-2012

https://doi.org/10.4081/reumatismo.2012.1

739

PDF: 819
Driving musculoskeletal health for Europe: EUMUSC.NET

A.D. Woolf

1-4

https://doi.org/10.4081/reumatismo.2011.1

21281

PDF: 806
A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs

G. Pasero, P. Marson

111-123

https://doi.org/10.4081/reumatismo.2011.111

2312

PDF: 1823
Pain in fibromyalgia and related conditions

G. Cassisi, P. Sarzi-Puttini, R. Casale, M. Cazzola, L. Boccassini, F. Atzeni, S. Stisi

72-86

06-06-2014

https://doi.org/10.4081/reumatismo.2014.767

4374

PDF: 2691
Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

07-01-2025

https://doi.org/10.4081/reumatismo.2025.1682

1833

PDF: 188
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients

Dilia Giuggioli, Rocco Magistro, Michele Colaci, Umberto Franciosi, Andrea Caruso, Clodoveo Ferri

26-30

https://doi.org/10.4081/reumatismo.2006.26

998

PDF: 1147
RETRACTED - Pain in systemic sclerosis

S. Stisi, P. Sarzi-Puttini, M. Benucci, G. Biasi, S. Bellissimo, R. Talotta, F. Atzeni

44-47

06-06-2014

https://doi.org/10.4081/reumatismo.2014.764

2067

PDF: 1175
The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

M. Varenna, D. Gatti

163-171

https://doi.org/10.4081/reumatismo.2010.163

1817

PDF: 1226
Treatment of hyperuricemia, gout and other crystalline arthritidies

F. Lioté

276-283

https://doi.org/10.4081/reumatismo.2011.276

1252

PDF: 1181
Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

233-238

https://doi.org/10.4081/reumatismo.2006.233

1051

PDF: 1016
Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience

C. Botsios, P. Ostuni, S. Todesco

44-51

https://doi.org/10.4081/reumatismo.2005.44

1181

PDF: 1767
Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

J. Mencarini, M. Spinicci, F. Bartalesi

144-147

16-12-2016

https://doi.org/10.4081/reumatismo.2016.897

2032

PDF: 1163
Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers

E. Catarsi, M. Doveri, A. Tavoni

79-81

27-05-2013

https://doi.org/10.4081/reumatismo.2013.79

3197

PDF: 911
CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture

R. Brizzolara, S. Soldano, P. Montagna, A. Sulli, B. Seriolo, B. Villaggio, P.F. Triolo, P. Clerico, L. Felli, L. Molfetta, M. Cutolo

80-85

https://doi.org/10.4081/reumatismo.2011.80

1473

PDF: 997
Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis

F.M. Perrotta, G. Guerra, A. De Socio, S. Scriffignano, E. Lubrano

1-8

22-05-2017

https://doi.org/10.4081/reumatismo.2017.976

2574

PDF: 1497
Chronic widespread pain in spondyloarthritis

F. Atzeni, L. Boccassini, M. Di Franco, A. Alciati, A. Marsico, M. Cazzola, G. Cassisi, P. Sarzi-Puttini

28-32

06-06-2014

https://doi.org/10.4081/reumatismo.2014.761

2753

PDF: 1668
The diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: the good, the bad and… ultrasonography!

G. Filippou, B. Frediani

125-127

19-07-2012

https://doi.org/10.4081/reumatismo.2012.125

868

PDF: 841
Osteoporosis and rheumatic diseases

N. Maruotti, A. Corrado, F.P. Cantatore

125-135

28-06-2014

https://doi.org/10.4081/reumatismo.2014.785

8339

PDF: 3540
Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment

M. Di Gangi, R. Foti, R. Leonardi, C. Leonetti, P. Castellino

169-172

https://doi.org/10.4081/reumatismo.2007.169

1041

PDF: 987
Biomarkers and prognostic stratification in psoriatic arthritis

L. Bogliolo, G. Crepaldi, R. Caporali

88-98

05-06-2012

https://doi.org/10.4081/reumatismo.2012.88

1494

PDF: 1323
Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca (KCS) in patients with primary Sjögren’s syndrome (SS) not responding to standard treatment with artificial tears

P. Ostuni, M.E.C. Battista, A. Furlan

119-124

https://doi.org/10.4081/reumatismo.2005.119

1006

PDF: 2057
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

285-303

31-03-2015

https://doi.org/10.4081/reumatismo.2014.799

2579

PDF: 2306

51 - 100 of 377 items << < 1 2 3 4 5 6 7 8 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy